APA (7th ed.) Citation

Navodnik, M. P., Reberšek, K., Klinar, K., Janež, A., & Podgornik, H. Adjuvant Treatment with Empagliflozin or Semaglutide Increases Endothelial Progenitor Cells in Subjects with Well-Controlled Type 1 Diabetes Mellitus. MDPI AG.

Chicago Style (17th ed.) Citation

Navodnik, Maja Preložnik, Katarina Reberšek, Katarina Klinar, Andrej Janež, and Helena Podgornik. Adjuvant Treatment with Empagliflozin or Semaglutide Increases Endothelial Progenitor Cells in Subjects with Well-Controlled Type 1 Diabetes Mellitus. MDPI AG.

MLA (9th ed.) Citation

Navodnik, Maja Preložnik, et al. Adjuvant Treatment with Empagliflozin or Semaglutide Increases Endothelial Progenitor Cells in Subjects with Well-Controlled Type 1 Diabetes Mellitus. MDPI AG.